This week, seven biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
- ADVERTISEMENT
-
- Poll of the Day
- Partners
- ADVERTISEMENT
AMGN
Recent Articles
79 Ways to Refocus Your Earnings Season Investing Strategy
Q2 earnings season is officially in full swing, and here are my takes on 79 stocks based on our Portfolio Grader system. More
3 Biotech Stocks That Could Keep Bombing
After years of unchecked rallying in biotech stocks, a correction is finally upon us. And as bad as things have been, the mean-reversion move could go even lower. More
7 Biotechnology Stocks to Buy Now
The grades of seven biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
Make This Blue-Chip Biotech a Cornerstone Holding
Amgen (AMGN) has established a new bull channel and MACD is flashing "buy." More
7 Biotechnology Stocks to Buy Now
This week, seven biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
Biggest Movers in Healthcare Stocks Now – BAX ICLR NVO AMGN
Healthcare stocks declined broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.4%. NYSE:BAX, NASDAQ:ICLR, NYSE:NVO, NASDAQ:AMGN, NYSE:CHE, NASDAQ:NPSP, NASDAQ:SHPG, NYSE:COV, NASDAQ:MDCO, NYSE:RMD, NASDAQ:HALO, NASDAQ:ISIS, NASDAQ:IRWD, NASDAQ:SGMO, NASDAQ:CLVS, NASDAQ:ENDP, NYSE:LCI, NASDAQ:ACAD, NYSE:VRX, NASDAQ:HZNP More
